The Delphi consensus process for International Recommendations on Acute Low Back Pain (ALBP) Management involved 48 responses across 3 rounds from 30 unique experts in 14 countries. The Group Discussion, which synthesized the consensus, involved 26 experts total (24 from Round 3 individual respondents plus 2 additional contributors).
The process demonstrated strong convergence toward consensus, with mean ratings improving from 3.20/5.00 in Round 1 to 4.41/5.00 in Round 3 among individual respondents. All seven topic areas achieved strong positive trends, with consensus strengthening substantially from Round 1 to Round 3. The final group consensus of 4.28/5.00 validates 10 key recommendations for evidence-based ALBP management.
| Round | Respondents | Notes |
|---|---|---|
| Round 1 | 4 | Initial responses |
| Round 2 | 15 | Expanded participation |
| Round 3 | 24 | 24 individual respondents |
| Group Discussion | 26 | 24 Round 3 individuals + 2 additional contributors |
Geographic Representation: 14 countries across all major regions (North America, Europe, Latin America, Africa, Asia)
Specialty Representation: 40+ clinical sub-specialties including anesthesiology, pain medicine, physical medicine and rehabilitation, orthopedic surgery, and neuroscience
Participation Continuity: 3 experts participated in all 3 rounds; 8 experts in 2 rounds; 19 experts in 1 round.
| Metric | Round 1 | Round 2 | Round 3 (Ind.) | Group Consensus |
|---|---|---|---|---|
| Respondents | 4 | 15 | 24 | 26 |
| Total Ratings | 232 | 870 | 1,392 | 58 |
| Mean Rating | 3.20 / 5 | 3.92 / 5 | 4.41 / 5 | 4.28 / 5 |
| Median | 3.0 | 4.0 | 5.0 | 5.0 |
| Positive (4–5) | 36.2% | 65.1% | 82.5% | 65.5% |
| Std Deviation | 1.14 | 1.05 | 0.81 | 0.94 |
| Rating 5 % | 16.4% | 35.5% | 50.3% | 44.8% |
The infographic below synthesises all key quantitative findings from the three-round Delphi process: consensus scores by section, the distribution of positive ratings across rounds, round-over-round convergence trajectories, and a comparison of individual versus group responses in the final round.
Strong convergence across all sections with most ratings meeting or exceeding the 4.0 consensus threshold.
Strong convergence across all sections with most ratings meeting or exceeding the 4.0 consensus threshold.
The 58-question survey is organised into 7 thematic sections. All sections showed consistent improvement across rounds.
| Section | R1 Mean | R2 Mean | R3 Mean | Group Mean | R3 Positive % | Consensus |
|---|---|---|---|---|---|---|
| General Key Messages | 3.68 | 4.14 | 4.51 | 4.79 | 90% | Strong |
| Assessment & Imaging | 3.32 | 3.50 | 4.20 | 3.14 | 75% | Moderate |
| Red Flags / Imaging Criteria | 3.85 | 4.13 | 4.55 | 4.60 | 86% | Strong |
| Self-Management (Rec. 1) | 3.19 | 4.03 | 4.62 | 5.00 | 90% | Unanimous |
| If Not Improving (Rec. 2a) | 2.67 | 3.79 | 4.38 | 4.33 | 83% | Strong |
| Radiculopathy-Specific (Rec. 2b) | 2.25 | 3.47 | 3.80 | 3.00 | 50% | Debated |
| Opioids (Rec. 3) | 3.17 | 4.11 | 4.56 | 4.33 | 88% | Strong |
Round 3 mean of 4.51/5 (90.5% positive). Group consensus achieved highest rating at 4.79/5 (92.9% positive). Experts strongly agree on foundational principles.
Round 3 individuals strongly supportive (4.20/5, 75% positive) but Group consensus more cautious (3.14/5, 14.3% positive), reflecting legitimate debate about specific imaging approaches.
Strong expert consensus (4.55/5 in R3, 4.60/5 in Group, 80–85% positive). Clear agreement on clinical warning signs requiring imaging.
Excellent consensus with highest mean rating in Group (5.00/5, 100% positive). Unanimous expert support for first-line self-care approach.
Strong convergence from 2.67 (R1) to 4.38 (R3 individuals). 83.3% positive in Round 3. Clear support for escalated non-pharmacological interventions.
Round 3 individuals achieved 50% positive (3.80/5) but Group consensus only 0% positive (3.00/5). Reflects ongoing clinical debate about steroid efficacy.
Strong expert consensus against opioid first-line use. Round 3: 88.4% positive (4.56/5). Group: 66.7% positive (4.33/5). Clear safety message across all rounds.
Physicians should acknowledge and validate the patient's pain. Patient education is critical. Shared decisions with patients are essential and foundational for all care pathways.
Stay active, stretch, and maintain range of motion. Apply heat, optimize anti-inflammatory medications, maintain daily activity, and avoid bed rest. Optimize nutrition, sleep hygiene, and hydration. Inactivity can slow recovery. Non-pharmacological options should be prioritised as first-line management.
Spinal manipulation, acupuncture, optimised NSAIDs, and muscle relaxants may be appropriate. Multiple non-drug options should be prioritised; improvement measured by outcomes.
Clear escalation pathway. Seek care if symptoms worsen or persist. Rule out underlying pathology and adjust management based on evaluation findings.
Evidence supports LOCAL epidural steroid injections for acute radiculopathy. Insufficient evidence for systemic steroids. Steroids only for radiculopathy — temporary relief, short durations only.
Red flags (bowel/bladder dysfunction, new or progressive numbness or weakness) warrant immediate evaluation. Clinical history indicating risk of cancer, infection, or fracture also requires prompt assessment and should be evaluated separately from red flag symptoms.
Imaging is warranted only with a red flag, history of cancer, or clinical suspicion of infection or fracture. Avoid routine imaging in uncomplicated ALBP — it does not improve outcomes and adds unnecessary cost and anxiety.
Avoid as first-line treatment. Try non-opioid treatments first. Generally ineffective for function. Unnecessary early use should be avoided.
If used: short-acting, time-limited, strict monitoring, regular reassessment. Counsel on safe use, side effects, and risk of dependence from long-term use. Avoid when safer alternatives are effective.
Psychosocial factors influence recovery. Escalate only when clinically appropriate. Combine physical, psychological, and pharmacological interventions — tailored to the individual.
The three-round Delphi consensus process involving 48 responses from 30 unique experts across 14 countries successfully achieved robust international expert agreement on 10 evidence-based recommendations for ALBP management.
The recommendations are ready for publication, dissemination to pain medicine societies globally, and clinical implementation. They represent validated, evidence-based, internationally endorsed guidance for managing acute low back pain in adults.